Search Menu

Paul Moser

Paul trained as a pharmacologist in the UK, first in Bristol, then in Bath for his Ph.D., specialising in chronopharmacology. He has spent over 30 years in the pharma industry in both big and medium pharma companies, biotech and also in contract research. After a few …

Read more

The Costs of Reproducibility

Improving the reproducibility of (biomedical) research is of great concern, especially to early-career researchers (ECRs). In this viewpoint article, Russell A. Poldrack from Stanford University outlines the potential costs for ECRs in adopting practices to improve reproducibility. He discusses the ways in which ECRs can achieve …

Read more

Scroll Up